Prestige Brands Holdings, Inc. to Release Fiscal 2016 Third Quarter Earnings on February 4th

TARRYTOWN, N.Y.--(BUSINESS WIRE)--

Prestige Brands Holdings, Inc. PBH today announced that it will issue its fiscal 2016 third quarter earnings release on Thursday, February 4, 2016 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. EST.

To access the call, listeners calling from within North America may dial 877-784-9650 about 15 minutes prior to the start of the call. Those wishing to access the call from outside North America should dial 530-379-4717. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of http://prestigebrands.com.

Telephonic replays will be available for two weeks following completion of the live call and can be accessed at 855-859-2056 within North America, and at 404-537-3406 from outside North America.

Prestige Brands markets and distributes brand name over-the-counter healthcare and household products throughout the U.S., Canada, Australia, and in certain other international markets. The Company's brands include Monistat® women's health products, Nix® lice treatments, Chloraseptic® sore throat treatments, Compound W® wart treatments, Clear Eyes® eye care products, Little Remedies® pediatric over-the-counter products, The Doctor's® NightGuard® dental protector, Efferdent® denture care products, Luden's® throat drops, Dramamine® motion sickness treatments, BC® and Goody's® headache remedies, Beano® gas prevention, Debrox® earwax remover, and in Canada, Gaviscon® antacid.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160108005554/en/